Papua New Guinea
Melanesia · Oceania · Physician brief
High malaria risk — chemoprophylaxis generally recommended
Papua New Guinea has year-round, high-intensity malaria transmission (mostly chloroquine-resistant P. falciparum) throughout the country below 2000 m, including coastal and island areas popular with travelers. Malaria chemoprophylaxis (atovaquone-proguanil, doxycycline, or mefloquine) is generally recommended in addition to strict mosquito protection. Discuss the right regimen with your travel medicine specialist well before departure.
CDC Yellow Book 2024 / EKRM ↗ · Updated 2026
Yellow fever certificate if arriving from a risk country
There is no yellow fever in Papua New Guinea, but a valid YF vaccination certificate is required on entry for travelers aged 1 year and over arriving from — or having transited the airport of — a country with risk of yellow fever transmission. Direct travel from Switzerland is not affected.
WHO / PNG immigration guidance ↗ · Updated 2026
Limited healthcare and remote areas
Medical facilities outside Port Moresby are limited, and serious illness or injury may require evacuation. Comprehensive travel and repatriation insurance is strongly advised. Carrying a personal first-aid kit and discussing emergency standby malaria treatment with your travel clinic is sensible for remote itineraries.
EKRM / CDC ↗ · Updated 2026
Vaccines
Disease-specific guidance
Malaria
HighHigh, year-round transmission throughout the country in areas below 2000 m, including coastal and island destinations. Most infections are chloroquine-resistant P. falciparum (about 75%), with P. vivax (about 25%) and rare P. malariae and P. ovale. Chemoprophylaxis is generally recommended alongside strict mosquito protection; only the highland areas above 2000 m are essentially risk-free.
- Risk area
- Countrywide below 2000 m, incl. coast & islands
- No risk
- Highlands above 2000 m
- Species
- P. falciparum (~75%), P. vivax (~25%)
- Resistance
- Chloroquine-resistant
- Prevention
- Chemoprophylaxis + mosquito protection
Yellow fever
NoneNo yellow fever risk in country. A YF vaccination certificate is required on entry for travelers aged 1 year and over arriving from — or having transited the airport of — a country with risk of yellow fever transmission. Direct travel from Switzerland is not affected.
Dengue
ModerateEndemic with year-round risk and periodic outbreaks, particularly in urban and lowland areas. Daytime mosquito-bite prevention is the main protection and also reduces Zika risk.
- Distribution
- Urban and lowland areas nationwide
- Season
- Year-round
- Mosquito
- Aedes aegypti — bites during daytime
General prevention
Food & water
Use bottled or filtered water, avoid ice from unverified sources, and pay close attention to food hygiene. Standard tropical precautions reduce risk of traveler's diarrhea, hepatitis A, and typhoid. Outside Port Moresby and a handful of resorts, hygiene standards are variable, so these precautions matter throughout the trip.
Mosquito protection
Rigorous round-the-clock mosquito protection is essential. Daytime-biting Aedes mosquitoes transmit dengue and Zika, while night-biting Anopheles transmit malaria across most of the country below 2000 m. Use DEET or picaridin repellent, cover up at dawn and dusk, and sleep under an insecticide-treated bed net in rural and lowland areas. Japanese encephalitis is also present in rural areas.
Sources
Based on CDC Travelers’ Health, CDC Yellow Book, and the Swiss Federal Vaccination Schedule (BAG). Always verify current recommendations before travel.
Visiting more than one country?
Build a combined itinerary and get merged recommendations across all destinations.
This brief is for informational purposes and does not replace personalized medical advice.
Consult a travel medicine specialist 4–8 weeks before departure.